TGFA and COVID-19: Consistent with reports of fibrotic lung abnormalities following SARS-CoV-2 infection, patients with COVID-19 had significantly higher concentrations of multiple epidermal and platelet-derived growth factors, including TGF-α, EGF, PDGF-AB/BB, and PDGF-AA30.